Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
INDUSTRY
×
pexidartinib
×
Clear all
Filters
3
NCT04488822
2025-09-09
PLX3397
Daiichi Sankyo
Phase 3
Active not recruiting
40 enrolled
15 charts
NCT02371369
2022-05-11
ENLIVEN
Daiichi Sankyo
Phase 3
Completed
120 enrolled
25 charts
1 FDA